Martin Yang, Oppenheimer senior analyst, joins 'Squawk on the Street' to discuss what Apple Intelligence is lacking that's ...
According to estimates by IDC and Canalys, overall iPhone market share fell 1% year over year in Q4 to 23% despite the ...
Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...
Apple shares rose more than 3% in premarket trading on Friday after the company forecast relatively strong sales growth, hinting at a recovery from a dip in iPhone sales as it rolls out artificial ...